Clinical trials
Completed Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
331 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 21 |
| 2001 | 13 |
| 2002 | 14 |
| 2003 | 16 |
| 2004 | 16 |
| 2005 | 18 |
| 2006 | 14 |
| 2007 | 18 |
| 2008 | 9 |
| 2009 | 15 |
| 2010 | 17 |
| 2011 | 17 |
| 2012 | 14 |
| 2013 | 11 |
| 2014 | 8 |
| 2015 | 13 |
| 2016 | 3 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 331 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 36 |
| M.D. Anderson Cancer Center | 21 |
| National Cancer Institute (NCI) | 19 |
| Memorial Sloan Kettering Cancer Center | 11 |
| Case Comprehensive Cancer Center | 10 |
| National Heart, Lung, and Blood Institute (NHLBI) | 10 |
| Children's Oncology Group | 8 |
| St. Jude Children's Research Hospital | 8 |
| Novartis Pharmaceuticals | 7 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 331 |
| Leukemia, Myeloid, Acute | 147 |
| Lymphoma, Non-Hodgkin | 133 |
| Leukemia | 130 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 128 |
| Burkitt Lymphoma | 116 |
| Myelodysplastic Syndromes | 105 |
| Lymphoma, Follicular | 102 |
| Hodgkin Disease | 100 |
| Lymphoma, Large B-Cell, Diffuse | 99 |
Trials
Showing 1 to 25 of 331. Each trial links to its page on Pharma Observatory.
231 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.